AVDL

Avadel Pharmaceuticals
AVDL

Overview Fund Activity

52 hedge funds and large institutions have $299M invested in Avadel Pharmaceuticals in 2014 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 15 increasing their positions, 7 reducing their positions, and 6 closing their positions.

Holders
52
Holders Change
+17
Holders Change %
+48.57%
% of All Funds
1.5%
Holding in Top 10
4
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+300%
% of All Funds
0.12%
New
23
Increased
15
Reduced
7
Closed
6
Calls
$925K
Puts
$825K
Net Calls
+$100K
Net Calls Change
+$92K

Top Buyers

1
JPMorgan Chase & Co
1
JPMorgan Chase & Co
New York
$20.3M
2
Jennison Associates
2
Jennison Associates
New York
$20.1M
3
BC
3
Broadfin Capital
New York
$70.6M
4
Millennium Management
4
Millennium Management
New York
$16.9M
5
CCM
5
Consonance Capital Management
New York
$14M

Top Sellers

1
IAM
1
Iridian Asset Management
Connecticut
$1.38M
2
Invesco
2
Invesco
Georgia
$0
3
CCI
3
Columbus Circle Investors
$0
4
BCM
4
Bourgeon Capital Management
Connecticut
$403K
5
VKH
5
Virtu KCG Holdings
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
TRCT
51
Tower Research Capital (TRC)
New York
$1K +$1K +100 New
Invesco
52
Invesco
Georgia
– -$631K -78,346 Closed
CCI
53
Columbus Circle Investors
– -$468K -58,132 Closed
VKH
54
Virtu KCG Holdings
New York
– -$116K -14,478 Closed
BWP
55
Baldwin Wealth Partners
Massachusetts
– -$101K -12,600 Closed
JMFC
56
J.M. Forbes & Co
Massachusetts
– -$88K -11,000 Closed
JIC
57
Joel Isaacson & Co
New York
– -$2K -210 Closed
1 2
3